Cargando…
COVID-19: ICU delirium management during SARS-CoV-2 pandemic—pharmacological considerations
Autores principales: | Andrews, Lauren J., Benken, Scott T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309692/ https://www.ncbi.nlm.nih.gov/pubmed/32576234 http://dx.doi.org/10.1186/s13054-020-03072-5 |
Ejemplares similares
-
COVID-19: ICU delirium management during SARS-CoV-2 pandemic
por: Kotfis, Katarzyna, et al.
Publicado: (2020) -
Letter to the editor: Quetiapine safety in ICU delirium management among SARS-CoV-2-infected patients
por: Khosravi, Mohsen
Publicado: (2021) -
Delirium in a pregnant woman with SARS-CoV-2 infection in India
por: Mahajan, Niraj N., et al.
Publicado: (2021) -
COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?
por: Kotfis, Katarzyna, et al.
Publicado: (2020) -
Safety considerations for the use of Point‐Of‐Care diagnostics during SARS‐CoV‐2 pandemic
por: Raimann, Florian J., et al.
Publicado: (2020)